Register entry

MacroGenics, Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 1 drug for further processing, 1 human prescription drug. By marketing category: BLA 1, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
injection, solution, concentrate1
solution1
RouteNDCs
intravenous1
Labeller name on the listingNDCs
macrogenics, inc2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
MARGENZAmargetuximab-cmkbinjection, solution, concentrate, intravenous74527-022BLA
-retifanlimabsolution74527-012DRUG FOR FURTHER PROCESSING
Compare

Other companies listing margetuximab-cmkb

Enquiry

Common questions

Is MacroGenics, Inc FDA approved?
MacroGenics, Inc holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does MacroGenics, Inc make?
2 products are listed under MacroGenics, Inc in the openFDA NDC Directory, most often as injection, solution, concentrate; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.